SignatureFD
PACB icon

SignatureFD’s Pacific Biosciences PACB Stock Holding History

SignatureFD’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$8.56K Buy
3,612
+1,733
+92% +$2.45K ﹤0.01% 2769
2026
Q2 		$3.16K Sell
1,879
-5,078
-73% -$7.38K ﹤0.01% 3012
2026
Q1 		$9.18K Sell
6,957
-510
-7% -$912 ﹤0.01% 2554
2025
Q4 		$14K Buy
7,467
+2,477
+50% +$4.76K ﹤0.01% 2274
2025
Q3 		$6.39K Buy
4,990
+2,270
+83% +$3.07K ﹤0.01% 2571
2025
Q2 		$3.37K Buy
2,720
+427
+19% +$493 ﹤0.01% 2719
2025
Q1 		$2.71K Sell
2,293
-2,161
-49% -$3.32K ﹤0.01% 2799
2024
Q4 		$8.15K Sell
4,454
-173
-4% -$338 ﹤0.01% 2438
2024
Q3 		$7.87K Buy
4,627
+2,870
+163% +$4.72K ﹤0.01% 2433
2024
Q2 		$2.41K Buy
1,757
+1,095
+165% +$2.21K ﹤0.01% 2715
2024
Q1 		$2.48K Buy
662
+189
+40% +$1.11K ﹤0.01% 2744
2023
Q4 		$4.64K Buy
473
+155
+49% +$1.27K ﹤0.01% 2522
2023
Q3 		$2.66K Hold
318
– – ﹤0.01% 2701
2023
Q2 		$4.23K Hold
318
– – ﹤0.01% 2573
2023
Q1 		$3.68K Sell
318
-61
-16% -$606 ﹤0.01% 2622
2022
Q4 		$3.1K Hold
379
– – ﹤0.01% 2654
2022
Q3 		$2K Buy
379
+83
+28% +$476 ﹤0.01% 2824
2022
Q2 		$1K Sell
296
-222
-43% -$1.35K ﹤0.01% 2976
2022
Q1 		$5K Buy
518
+457
+749% +$5.26K ﹤0.01% 2494
2021
Q4 		$1K Sell
61
-108
-64% -$2.61K ﹤0.01% 2967
2021
Q3 		$4K Buy
+169
New +$5.01K ﹤0.01% 2452
2021
Q2 		– Sell
-17
Closed -$1K – 3020
2021
Q1 		$1K Buy
+17
New +$595 ﹤0.01% 2658
2020
Q1 		– Sell
-247
Closed -$1K – 2409
2019
Q4 		$1K Buy
+247
New +$1.26K ﹤0.01% 2074

Other funds holding PACB

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Capricorn Fund Managers
Capricorn Fund Managers London, United Kingdom $1.06B AUM 45.98% 1-Year Est. Return
Bourne Lent Asset Management
Bourne Lent Asset Management Pawling, New York $293M AUM 24.01% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Carret Asset Management
Carret Asset Management New York $1.14B AUM 25.06% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return
Mirador Capital Partners
Mirador Capital Partners Pleasanton, California $859M AUM 41.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

SignatureFD's PACB Position: Q3 2026 in Review

SignatureFD increased its Pacific Biosciences (PACB) stake by 92% in Q3 2026, buying an estimated $2.45K and bringing the position to 3,612 shares worth $8.56K. The position accounts for ﹤0.01% of the portfolio, ranked #2769.

SignatureFD first reported a position in PACB in Q4 2019 and has held it in 23 quarters since. The position peaked at $14K in Q4 2025. 67 funds tracked by Wall St. Rank hold PACB as of Q3 2026.

  • SignatureFD held 3,612 shares of Pacific Biosciences worth $8.56K as of Q3 2026.
  • SignatureFD bought 1,733 Pacific Biosciences shares in Q3 2026, an estimated $2.45K.
  • Pacific Biosciences made up ﹤0.01% of SignatureFD's portfolio in Q3 2026, its #2769 holding.
  • SignatureFD first reported a position in Pacific Biosciences in Q4 2019 and has held it in 23 quarters since.
  • SignatureFD's Pacific Biosciences position peaked at $14K in Q4 2025.
  • 67 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2026.

Based on SignatureFD's 13F filing for Q3 2026, filed 23 Oct 2026.